SAN DIEGO – All multiple sclerosis patients taking natalizumab (Tysabri) who were diagnosed with progressive multifocal leukoencephalopathy (PML) before symptoms appeared were still alive a year later ...
APL is a distinct subtype of myeloid leukaemia that in almost 100% of cases is associated with chromosomal translocations involving the PML and retinoic acid receptor α (RARA) loci, leading to the ...
May 31, 2011 — The prognosis of natalizumab (Tysabri; Biogen Idec)–associated progressive multifocal leukoencephalopathy (PML) in patients with multiple sclerosis (MS) appears to be better than for ...
BARCELONA, Spain — A quantitative test for antibodies to the JC virus (JCV) stratifies antibody-positive patients with multiple sclerosis (MS) for their risk of contracting progressive multifocal ...
PML stands for progressive multifocal leukoencephalopathy. It’s an aggressive viral disease of the central nervous system. The virus attacks cells that make myelin. Myelin is a fatty substance that ...
Fumaric acid esters, which are prescribed for the treatment of psoriasis and multiple sclerosis, are considered to have a favorable risk profile. However, treatment-related progressive multifocal ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results